Cuprina Holdings Rallies as Traders Revisit Recent FDA Clearance and Nasdaq Compliance Update

By: Quiver PriceTracker

Posted: an hour ago / June 24, 2026 5:40 p.m. UTC

CUPR

Cuprina Holdings (CUPR) is up 44.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued momentum from two recent company-specific catalysts: U.S. FDA 510(k) clearance for MEDIFLY Maggots and the removal of a Nasdaq delisting overhang. There does not appear to be a fresh major announcement today, so the jump may reflect follow-through buying in a thin, highly volatile stock after those updates.

Details:

On June 15, Cuprina said its subsidiary received FDA 510(k) clearance for MEDIFLY Maggots, a wound-care product for debriding non-healing necrotic skin and soft tissue wounds.

The company described the product as the first U.S.-cleared maggot debridement therapy using the Lucilia cuprina species, expanding its regulatory position in chronic wound care.

Just days earlier, Cuprina said it regained compliance with Nasdaq’s minimum bid price rule, which canceled a previously scheduled hearing and allowed the shares to remain listed.

This could be because traders are still reacting to those back-to-back regulatory and listing milestones, with speculative momentum amplified by the stock’s small size and recent history of sharp swings.

Sources:

SEC, Cuprina Holdings Investor Relations, StockTitan

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CUPR Hedge Fund Activity

We have seen 2 institutional investors add shares of $CUPR stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CITADEL ADVISORS LLC added 37,281 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,912
XTX TOPCO LTD added 35,457 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,378
STONEX GROUP INC. removed 13,260 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,305
UBS GROUP AG removed 11,624 shares (-97.0%) from their portfolio in Q1 2026, for an estimated $3,402
TWO SIGMA SECURITIES, LLC removed 10,346 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,028
PROSPECT FINANCIAL GROUP LLC removed 9,615 shares (-38.6%) from their portfolio in Q1 2026, for an estimated $2,814
CLEAR STREET GROUP INC. removed 100 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $40

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.